Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Area of Science:

• Urology
• Pathology
• Oncology

Background:

• Optimal prostate biopsy balances cancer detection, accuracy, and risk stratification.
• Current consensus on core number, location, labeling, and processing is lacking.
• Accurate prostate biopsy guides treatment selection and disease localization.

Purpose of the Study:

• Define optimal number and location for primary prostate biopsy cores.
• Establish best practices for labeling biopsy cores for pathological processing.
• Determine the maximum number of cores per container for accurate histological evaluation.

Main Methods:

• Bibliographic search of PubMed up to July 2012 (approx. 550 articles).
• Articles categorized and data extracted based on review objectives.
• Recommendations synthesized from literature review and clinical experience.

Main Results:

• 10-12 core protocols increase cancer detection and negative predictive value versus sextant sampling.
• Beyond 12 cores, diagnostic yield increase is marginal; saturation biopsies lack strong evidence.
• Apical and lateral peripheral zone sampling improves detection; transition zone sampling does not.
• Individual core site labeling offers limited clinical benefit; laterality is helpful.
• More than 2 cores per container compromise pathological evaluation and detection rates.

Conclusions:

• A 12-core systematic biopsy with apical and far-lateral sampling maximizes cancer detection and aids therapy decisions.
• Individual core site labeling lacks compelling evidence for improving clinical decision-making.
• Package no more than 2 cores per jar to ensure accurate histological evaluation and cancer detection.